Skip to main content

Table 3 Ratios between different subpopulations of T-lymphocytes in groups of patients, Me (Q1 – Q3)

From: T-helper-1, T-helper-17, T-regulatory lymphocytes in hypertensive patients with diabetes mellitus type 2 or impaired glucose tolerance: association with clinical and metabolic parameters in a case control study

Ratio

Healthy volunteers

Hypertensive patients

Hypertensive diabetic patients

Hypertensive patients with IGT

(n = 12)

(n = 7)

(n = 20)

(n = 7)

Treg/Th17 (media)

59.13 (22.57–70.58)

49.08 (47.60–61.64)

20.55 (16.40–35.58)*, #

32.43 (10.17–46.54)#

Treg/Th1 (media)

59.14 (22.57–70.58)

84.14 (66.38–87.00)

31.56 (19.27–37.63) *, #

48.25 (13.90–86.43)

Treg/Th17 (PMA + ionomycin)

15.33 (12.59–16.80)

8.99 (7.10–9.20)*

7.05 (4.46–12.57)*

6.08 (4.54–27.50)

Treg/Th1 (PMA + ionomycin)

0.57 (0.51–0.60)

0.46 (0.37–0.47)

0.19 (0.14–0.29)*, #

0.25 (0.12–0.39)*

  1. Me median, Q 1 25th percentile, Q 3 75th percentile
  2. *p < 0.05 compared to healthy volunteers, #p < 0.05 compared to patients with AH